Principal Financial Group
PRAX icon

Principal Financial Group’s Praxis Precision Medicines PRAX Stock Holding History

Principal Financial Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$643K Buy
1,922
+769
+67% +$243K ﹤0.01% 1987
2026
Q1 		$371K Buy
1,153
+158
+16% +$48.9K ﹤0.01% 2049
2025
Q4 		$293K Buy
+995
New +$185K ﹤0.01% 2093
2023
Q4 		– Sell
-2,310
Closed -$59.3K – 2448
2023
Q3 		$59.3K Buy
2,310
+192
+9% +$3.63K ﹤0.01% 2339
2023
Q2 		$36.5K Buy
2,118
+847
+67% +$13K ﹤0.01% 2380
2023
Q1 		$15.4K Buy
1,271
+18
+1% +$760 ﹤0.01% 2432
2022
Q4 		$44.7K Buy
+1,253
New +$39.1K ﹤0.01% 2372

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Principal Financial Group's PRAX Position: Q2 2026 in Review

Principal Financial Group increased its Praxis Precision Medicines (PRAX) stake by 67% in Q2 2026, buying an estimated $243K and bringing the position to 1,922 shares worth $643K. The position accounts for ﹤0.01% of the portfolio, ranked #1987.

Principal Financial Group first reported a position in PRAX in Q4 2022 and has held it in 7 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Principal Financial Group held 1,922 shares of Praxis Precision Medicines worth $643K as of Q2 2026.
  • Principal Financial Group bought 769 Praxis Precision Medicines shares in Q2 2026, an estimated $243K.
  • Praxis Precision Medicines made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #1987 holding.
  • Principal Financial Group first reported a position in Praxis Precision Medicines in Q4 2022 and has held it in 7 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.